Biomedical device company Biotronik has received U.S. Food and Drug Administration (FDA) approval for its Iperia ProMRI HF-T cardiac resynchronization defibrillator.
The defibrillator is designed to provide heart failure patients with access to MRI studies, according to the vendor. It also offers remote monitoring with daily automatic transmission and closed-loop stimulation that adapts the heart rate in response to physiological demands, Biotronik said.
